VF
MRNA icon

VitalStone Financial’s Moderna MRNA Stock Holding History

VitalStone Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$134 Hold
2
– – ﹤0.01% 472
2024
Q2 		$238 Hold
2
– – ﹤0.01% 454
2024
Q1 		$0 Hold
2
– – ﹤0.01% 551
2023
Q4 		$0 Hold
2
– – ﹤0.01% 543
2023
Q3 		$0 Sell
2
-70
-97% -$7.81K ﹤0.01% 552
2023
Q2 		$11K Buy
72
+20
+38% +$2.67K 0.01% 621
2023
Q1 		$14K Sell
52
-20
-28% -$3.3K 0.01% 191
2022
Q4 		$13K Buy
+72
New +$11.8K 0.01% 319

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VitalStone Financial's MRNA Position: Q3 2024 in Review

VitalStone Financial held its Moderna (MRNA) position steady in Q3 2024 at 2 shares worth $134. The position accounts for ﹤0.01% of the portfolio, ranked #472.

VitalStone Financial first reported a position in MRNA in Q4 2022 and has held it in 8 quarters since. The position peaked at $14K in Q1 2023. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • VitalStone Financial held 2 shares of Moderna worth $134 as of Q3 2024.
  • VitalStone Financial left its Moderna share count unchanged in Q3 2024.
  • Moderna made up ﹤0.01% of VitalStone Financial's portfolio in Q3 2024, its #472 holding.
  • VitalStone Financial first reported a position in Moderna in Q4 2022 and has held it in 8 quarters since.
  • VitalStone Financial's Moderna position peaked at $14K in Q1 2023.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on VitalStone Financial's 13F filing for Q3 2024, filed 11 Oct 2024.